Universal Health Services, Inc. (UHS) Stock: Price, Forecast & Analyst Target
Universal Health Services, Inc. (UHS) — MoonshotScore 94/100 (Exceptional band), calculated Oct 5, 2026. Price $177.21 (+0.85%), as of the Oct 5, 2026 trading session; market cap $10.7B. Expected results Oct 26, 2026.
Educational signal · not a buy or sell recommendation · How to read this
Market value / cash and short-term investments: 77.09× (market value Oct 5, 2026; cash Jun 30, 2026) · expected results Oct 26, 2026
Universal Health Services, Inc. · UHS · NYSE · Healthcare · Medical - Care Facilities
Research dated 2026-09-13: Universal Health Services earns most of its revenue by treating patients in acute-care hospitals and behavioral-health facilities, with outpatient sites, facility management and commercial health insurance extending that base. The case depends on whether rising revenue and cash generation can outrun softer patient-volume expectations, reimbursement pressure and a debt load that dwarfs cash.
Price as of Oct 5, 2026
Key Statistics
MoonshotScore v2 · Universal Health Services (UHS)
ExceptionalWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
Elite quality and elite growth, at a dirt-cheap price, though the balance sheet is only middling. Business Quality: Elite; Financial Safety: Okay; Valuation: Cheap; Growth Durability: Compounding; Momentum: Rising.
- quarterly revenue $4.64B (Q2 FY2026, quarter ended Jun 2026)
- EPS beat 6 of 8
- Altman Z 3.11 · Piotroski F 8
Helping: business quality, an attractive price, durable growth
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 93 | Exceptional | |
| 94 | Exceptional | |
| 94 | Exceptional | |
| 94 | Exceptional | |
| 94 | Exceptional | |
| 94 | Exceptional |
The score was 94 in the stored Oct 4, 2026 snapshot and remains 94 in the current publication computed Oct 5, 2026 (0); the largest pillar moves were Growth Durability -1; the pillar moves offset under the sector-relative weighting, so the headline score is unchanged.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · Educational signal · not a buy or sell recommendation · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $177.21 | |
| Change on the day | +0.85% | |
| 52-week range | $140.08 – $246.33 | |
| Market capitalisation | $10.7B | |
| Price / earnings (trailing) | 6.87 | |
| Shares traded on the day | 155K | |
| Beta (volatility vs the S&P 500) | 1.06 | |
| Dividends per share (last 12 months) | $0.80 | |
| Dividend yield (last 12 months) | 0.46% |
Price & events
Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file or a dated event that is not a results report. Numbers key to the dated list. Point at or tab to any week for its close.
Events behind the price
- · Earnings results · above the recorded estimate
- · Earnings results · below the recorded estimate
- · Earnings results · above the recorded estimate
- · Earnings results · above the recorded estimate
- · Earnings call · management outlook
Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.
Upcoming events
Management outlook
Year to date, facility year to date facility same-store facility acute care adjusted admissions growth through the second quarter of 2026 was 1.4% and we believe it is appropriate to fine tune our volume guidance for the full year to a range of 1.5% to 2.5% or 50 basis points lower at the midpoint of our prior range to reflect the year to date trends.
Steve G. Filton · Statement from
Based on the trends during the first half of 2026, we expect the full year pretax impact to be within the upper half of our originally contemplated guidance range or approximately $85 million while the first half decline in exchange volumes was below the 25%-plus range in our original forecast, we believe our impact estimate is supported by the trends we have observed year to date in our business and other dynamics such as shifts in the metal tier that are playing out within the exchange market.
Steve G. Filton · Statement from
Statement dates identify the earnings call, not a deadline. Management expectations and provider estimates can change.
Read management statementsOther perspectives
Council score for Universal Health Services (UHS): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
5-Factor Breakdown
Legends Council
5 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Oct 4, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 10, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.
Readings on this page are from Oct 5, 2026, except a card that shows its own read date.
Watch the UHS film — every key number, told as a short cinematic story
~2 min · open the film
What is Universal Health Services (UHS), and what does it report?
Short answer · as of
UHS owns and manages acute-care hospitals, behavioral-health treatment centers and related outpatient facilities.
Research dated 2026-09-13.
UHS owns and manages acute-care hospitals, behavioral-health treatment centers and related outpatient facilities. Acute care contributes more revenue, but behavioral health is substantial enough that UHS should not be read as merely a general-hospital operator; its services range from surgery, emergency medicine and oncology to mental-health treatment.
Reported revenue therefore measures care delivered across distinct settings and demand units. Acute-care activity is discussed through adjusted admissions, while behavioral-health activity is tracked through patient days; commercial insurance and centralized management services add further operating breadth.
What do the latest results show for Universal Health Services (UHS)?
Short answer · as of
The most recent reported quarter, Q2 FY2026, carried revenue of $4.64B.
Research dated 2026-09-13.
The latest reported period extended the longer run of revenue growth and produced higher operating profit, net income and diluted earnings than the comparable period. Revenue and earnings also exceeded market expectations, following a mixed history in which earnings execution was generally steadier than revenue execution.
Management nevertheless reduced its volume outlook for acute care and behavioral health after softer activity trends. It also expects exchange-related pressure near the unfavorable end of its prior range, citing enrollment and metal-tier shifts, while a Texas behavioral-health hospital is operating with limited census and losses during recertification.
Where is operating spending going?
Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.
- Latest quarter · revenue
- $4.64B Jun 30, 2026
- Latest quarter · SG&A
- $2.14B Jun 30, 2026
- Latest quarter · FMP standardized operating result
- $516.67M Jun 30, 2026
| Period end | Revenue | R&D | SG&A | FMP standardized operating result |
|---|---|---|---|---|
| Jun 30, 2026 | $4.64B | Not available | $2.14B | $516.67M |
| Mar 31, 2026 | $4.50B | Not available | $2.13B | $502.86M |
| Dec 31, 2025 | $4.49B | Not available | $2.09B | $517.23M |
| Sep 30, 2025 | $4.50B | Not available | $2.11B | $521.69M |
USD. The operating result is the FMP-standardized value supplied by FMP; it may differ from a filing’s GAAP loss from operations when the provider classifies separately presented items differently. It is not net income or cash flow.
Did results meet expectations?
Reported earnings and revenue alongside the estimates recorded by the provider.
- Latest report · revenue
- $4.64B Jul 27, 2026
- Latest report · revenue estimate
- $4.58B Jul 27, 2026
- Latest report · revenue vs estimate
- Above estimate Jul 27, 2026
- Latest report · EPS vs estimate
- Above estimate Jul 27, 2026
| Report date | Revenue · reported | Revenue · estimate | EPS · reported | EPS · estimate |
|---|---|---|---|---|
| Jul 27, 2026 | $4.64B | $4.58B | $5.9800 | $5.9400 |
| Apr 27, 2026 | $4.50B | $4.39B | $5.6200 | $5.4100 |
| Feb 25, 2026 | $4.49B | $4.50B | $5.8800 | $5.9200 |
| Oct 27, 2025 | $4.50B | $4.50B | $5.6900 | $4.6600 |
Dates are report dates, not fiscal period ends. Revenue is in USD; EPS is USD per share, rounded to four decimals. The earnings feed does not establish a basic, diluted or adjusted basis. Earnings-feed EPS may differ from statement EPS; the two series are not combined.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2026 | $4.64B | $358M | $5.98 (diluted) |
| Q1 FY2026 | $4.50B | $349M | $5.65 (diluted) |
| Q4 FY2025 | $4.49B | $446M | $7.01 (diluted) |
| Q3 FY2025 | $4.50B | $373M | $5.74 (diluted) |
What are the financial strengths and risks for Universal Health Services (UHS)?
Short answer
Cash and short-term investments were $138.80M at the Jun 30, 2026 balance-sheet date. Operating cash flow was $443.30M for the quarter ended Jun 30, 2026, meaning operations generated cash. These figures do not establish a cash runway.
Research dated 2026-09-13.
Operating cash flow has remained positive and has exceeded capital spending throughout the displayed quarterly series. That gives UHS internally generated funding for a facility-heavy model, and trailing profitability and return measures remain healthy.
The balance sheet is the sharper constraint. Cash has stayed within a relatively narrow range while debt is far larger, leaving substantial net debt despite near-term liquidity ratios around balance. Continued dividends add a recurring cash commitment, though recent payments have been stable.
The business is especially exposed when reimbursement stops but facility costs continue. The Texas recertification case makes that mechanism concrete: restricted patient activity and unavailable government or managed-care reimbursement are expected to produce operating losses.
How much cash does the business generate or use?
Quarterly operating cash flow shows cash generated or used by operations.
- Latest quarter · operating cash flow
- $443.30M Jun 30, 2026
- Previous quarter · operating cash flow
- $401.63M Mar 31, 2026
| Period end | Operating cash flow | Capital expenditure (reported) |
|---|---|---|
| Jun 30, 2026 | $443.30M | −$227.63M |
| Mar 31, 2026 | $401.63M | −$217.16M |
| Dec 31, 2025 | $574.69M | −$281.22M |
| Sep 30, 2025 | $380.68M | −$247.57M |
Operating cash-flow bars share one scale and show magnitude; negative values mean cash used.
USD. Negative operating cash flow means cash used. Capital expenditure keeps the provider’s reported sign; it is not added here to estimate free cash flow or runway.
What should you watch next at Universal Health Services (UHS)?
Short answer · as of
The next earnings report is expected on Oct 26, 2026.
Research dated 2026-09-13.
Watch acute-care adjusted admissions and behavioral-health patient days against management’s reduced ranges. Stabilization would support the revenue trend; further weakening would make recent profit growth harder to sustain, particularly while exchange reimbursement remains a headwind.
The scheduled earnings update carries expectations for higher revenue but softer per-share earnings than the latest reported period. Cash conversion after capital spending, debt movement and any update on the Texas facility’s certification should matter more than a headline revenue beat by itself.
Recent filings also include material agreements and borrowing-related disclosures. Given the gap between debt and cash, changes in financing commitments deserve attention alongside operating results.
What management is planning
Management expectations, not completed milestones or guarantees. Selected verbatim excerpts; dates follow the transcript provider.
Year to date, facility year to date facility same-store facility acute care adjusted admissions growth through the second quarter of 2026 was 1.4% and we believe it is appropriate to fine tune our volume guidance for the full year to a range of 1.5% to 2.5% or 50 basis points lower at the midpoint of our prior range to reflect the year to date trends.
Steve G. Filton ·
Based on the trends during the first half of 2026, we expect the full year pretax impact to be within the upper half of our originally contemplated guidance range or approximately $85 million while the first half decline in exchange volumes was below the 25%-plus range in our original forecast, we believe our impact estimate is supported by the trends we have observed year to date in our business and other dynamics such as shifts in the metal tier that are playing out within the exchange market.
Steve G. Filton ·
Year to date, same facility adjusted patient day growth through the second quarter of 2026 was 1.5%, and we believe it is appropriate to fine tune our volume guidance for the full year to a range of 1.0% to 2.0% 100 basis points lower than the prior range at the midpoint to reflect year to date trends and an outlook for second half volumes to be similar to Q2 performance.
Steve G. Filton ·
As it relates to our behavioral health hospital in Texas that is in the process of getting recertified we stopped receiving reimbursement at the end of April and do not expect to receive reimbursement from government or managed care sources until we regain certification, which we anticipate in 2027. The facility will operate in the meantime with limited patient census and therefore, we will incur operating losses and will be excluded the facility will be excluded from our same facility performance.
Steve G. Filton ·
How does Universal Health Services compare with its peers?
Short answer
Universal Health Services's score ranks 2nd of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
Research dated 2026-09-13.
Against a pure acute-care hospital operator, UHS has a meaningful behavioral-health platform whose demand is reflected in patient days rather than hospital admissions. Against a behavioral-health specialist, it has a larger acute-care operation spanning emergency, surgical, diagnostic and specialty medicine.
That mix diversifies the settings in which UHS treats patients, but it does not remove shared exposure to reimbursement and facility utilization. Ownership and management of facilities, centralized support functions and a commercial insurance operation also make the model broader than a straightforward collection of hospitals.
| Company | Price | Market value | Score |
|---|---|---|---|
| $231.84 Oct 5, 2026 | $3.60B | 98 5-pillar Oct 5, 2026 | |
| Universal Health Services (UHS) — this page | $177.21 | $10.7B | 94 |
| $12.17 Oct 5, 2026 | $4.59B | 93 5-pillar Oct 5, 2026 | |
| $122.38 Oct 5, 2026 | $11.9B | 90 5-pillar Oct 5, 2026 | |
| $262.01 Oct 5, 2026 | $21.2B | 89 5-pillar Oct 5, 2026 | |
| $513.54 Oct 5, 2026 | $6.63B | 87 5-pillar Oct 5, 2026 | |
| $22.66 Oct 5, 2026 | $12.0B | 83 5-pillar Oct 5, 2026 | |
| $435.10 Oct 5, 2026 | $92.4B | 82 5-pillar Oct 5, 2026 | |
| $23.45 Oct 5, 2026 | $3.39B | 81 5-pillar Oct 5, 2026 | |
| $12.29 Oct 5, 2026 | $2.68B | 81 5-pillar Oct 5, 2026 | |
| $174.16 Oct 5, 2026 | $10.1B | 75 5-pillar Oct 5, 2026 | |
| $178.11 Oct 5, 2026 | $11.5B | 75 5-pillar Oct 5, 2026 | |
| $88.09 Oct 5, 2026 | $15.2B | 61 5-pillar Oct 5, 2026 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Price target, low to high
- $166.00 – $290.00
- Consensus target
- $193.00
- Median target
- $189.00
Consensus record · Captured .
Measured against a quoted price of $177.21 (as of Oct 5, 2026).
Insider activity
Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated May 27, 2026
- Transactions
- 18
- Identified insiders
- 6
- Purchases
- 0
- Sales
- 0
- Other transactions
- 18
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
- Institutional ownership
- 86.5% Period end Jun 30, 2026
- Previous quarter · ownership
- 84.5% Prior to period end Jun 30, 2026
- Reporting holders
- 615 Period end Jun 30, 2026
- Previous quarter · holders
- 664 Prior to period end Jun 30, 2026
| Holders in provider snapshot | Shares |
|---|---|
| First Eagle Investment Management, LLC | 4,554,670 |
| Blackrock, INC. | 4,059,826 |
| Vanguard Capital Management LLC | 3,392,199 |
| Vanguard Portfolio Management LLC | 2,452,177 |
| Dimensional Fund Advisors LP | 2,210,595 |
Quarterly filings lag the period end. Holder rows are names in the provider snapshot, not a verified ranking; individual filing dates are not supplied. Related managers may appear separately, so these positions are not summed. Holder snapshot as of Jun 30, 2026.
What has been published about Universal Health Services (UHS)?
Common Questions About UHS (Healthcare)
Research dated 2026-09-13; the answers below are from that research, and the full attribution is under Sources. The last 3 questions are answered from this page's own dated data, not from the research.
Why do UHS acute-care admissions and behavioral-health patient days matter separately?
They represent different units of demand inside UHS. Acute-care performance depends on adjusted admissions, while behavioral-health performance depends on occupied treatment days, so weakness can emerge on either side without moving in lockstep.
What is happening at the UHS behavioral-health hospital in Texas?
The facility stopped receiving government and managed-care reimbursement while seeking recertification. UHS expects limited patient census and operating losses during that process.
Does UHS operate as a health insurer as well as a hospital company?
UHS provides commercial health insurance, but acute-care hospitals and behavioral-health services remain its principal reported revenue segments. Insurance broadens the model without replacing patient care as its economic core.
Why can UHS revenue rise while patient-volume guidance falls?
Reported revenue and profit describe completed activity across the whole business, whereas management’s guidance addresses the pace of future admissions and patient days. The latest results remained strong even as management tempered volume expectations and highlighted exchange-related reimbursement pressure.
What is the UHS stock price today?
The last price recorded on this page for Universal Health Services, Inc. (UHS) is $177.21, as of the Oct 5, 2026 trading session (source: Financial Modeling Prep (FMP) · quote). It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What is the UHS price target?
The analyst consensus price target for Universal Health Services, Inc. (UHS) is $193.00 (range $166.00 to $290.00, median $189.00), per FMP data captured Oct 5, 2026. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.
Does UHS pay a dividend?
Yes. Universal Health Services, Inc. (UHS) shows a trailing 12-month dividend yield of 0.46%, as of Oct 2, 2026, in the data on this page. Payout ratio and cash-flow coverage decide whether it can last, and past dividends do not guarantee future payments.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Research written by Codex (gpt-5.6-sol) on 2026-09-13. AI-authored analysis; source dates are shown with each answer. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources — records for every figure on this page (82 figures)
The 82 rows below are exactly the facts the evidence-backed sections of this page printed — the 10-second verdict, the MoonshotScore, price and market value, the five questions with their receipts, and the records behind this page. Known dates and sources are recorded on their own rows; an em dash or UNRECORDED tier preserves a stored observation without inventing either. The quarterly income statement is provider-standardized (FMP) under one row, and scale definitions — a 0-100 rating, the band ladder, the Piotroski 0–9 range — are fixed rather than measured. No number in those sections was generated by a model. The register does not cover quoted third-party headlines, the dated council readings, or the Frequently Asked Questions; each of those says where it came from where it stands.
"As of" is the date the value is true for where the source carries one — a quarter end, a filing date, a price close, the day the score was computed. A cached observation with no source date remains undated; the page publication date is not used as a substitute.
OFFICIAL — 2 facts from SEC filings and earnings calls
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
prod.outlook | Management outlook — call excerpts | Steve G. Filton (Jul 28, 2026): Year to date, facility year to date facility same-store facility acute care adjusted admissions growth through the second quarter of 2026 was 1.4% and we believe it is appropriate to fine tune our volume guidance for the full year to a range of 1.5% to 2.5% or 50 basis points lower at the midpoint of our prior range to reflect the year to date trends. Steve G. Filton (Jul 28, 2026): Based on the trends during the first half of 2026, we expect the full year pretax impact to be within the upper half of our originally contemplated guidance range or approximately $85 million while the first half decline in exchange volumes was below the 25%-plus range in our original forecast, we believe our impact estimate is supported by the trends we have observed year to date in our business and other dynamics such as shifts in the metal tier that are playing out within the exchange market. Steve G. Filton (Jul 28, 2026): Year to date, same facility adjusted patient day growth through the second quarter of 2026 was 1.5%, and we believe it is appropriate to fine tune our volume guidance for the full year to a range of 1.0% to 2.0% 100 basis points lower than the prior range at the midpoint to reflect year to date trends and an outlook for second half volumes to be similar to Q2 performance. Steve G. Filton (Jul 28, 2026): As it relates to our behavioral health hospital in Texas that is in the process of getting recertified we stopped receiving reimbursement at the end of April and do not expect to receive reimbursement from government or managed care sources until we regain certification, which we anticipate in 2027. The facility will operate in the meantime with limited patient census and therefore, we will incur operating losses and will be excluded the facility will be excluded from our same facility performance. | OFFICIAL | Company earnings call, transcript via Financial Modeling Prep (FMP) — Selected verbatim statements from the latest available call, dated by the transcript provider. Management expectations, not completed milestones or guarantees. Relative dates retain the speaker's wording. | |
id.hq | SEC filing business address | King OF Prussia, PA | OFFICIAL | SEC EDGAR filer business address — The SEC filer business address. Our market-data provider separately lists "Universal Corporate Center, King of Prussia, PA, 19406-0958, US". |
FMP — 70 facts from Financial Modeling Prep endpoint families
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
earn.next | Next earnings date | Oct 26, 2026 | FMP | Financial Modeling Prep (FMP) earnings calendar — The date is our provider's estimate until the company confirms it. | |
px.last | Latest provided price | $177.21 | FMP | Financial Modeling Prep (FMP) · quote — Dated to the US trading session the price belongs to, derived from the quote record's timestamp (weekend and pre-open reads roll back to the previous weekday; exchange holidays are not modelled). The record does not establish an exchange execution time. Retrieved 2026-10-05T18:22:10.000Z. | |
px.change | Change on the day | +0.85% | FMP | Financial Modeling Prep (FMP) · quote | |
px.mcap | Market capitalisation | $10.7B | FMP | Financial Modeling Prep (FMP) · quote — Date unknown Market cap record date: 2026-10-05. FMP quote timestamp: 2026-10-05T18:22:10.000Z. Captured from FMP at 2026-10-05T18:22:31.479Z. No share-count basis is inferred; this page preserves the reported amount instead of recalculating it from shares. | |
px.change_abs | Change on the day, in dollars | +$1.49 | FMP | Financial Modeling Prep (FMP) · quote | |
fin.q_revenue | Revenue, Q2 FY2026 | $4.64B | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
px.pe | Price / earnings (trailing) | 6.87 | FMP | Financial Modeling Prep (FMP) · quote | |
px.volume | Shares traded on the day | 155K | FMP | Financial Modeling Prep (FMP) · quote | |
px.beta | Beta | 1.06 | FMP | Financial Modeling Prep (FMP) company profile | |
id.ceo | Chief executive | Marc D. Miller | FMP | Financial Modeling Prep (FMP) key executives (proxy-derived) — Titles and pay come from the company's proxy statement as our provider parsed it. | |
id.founder | Founder named in the filing | Alan Miller — Founder & Executive Chairman of the Board | FMP | Financial Modeling Prep (FMP) key executives (proxy-derived) — Titles and pay come from the company's proxy statement as our provider parsed it. | |
id.employees | Employees | 101,500 | FMP | Financial Modeling Prep (FMP) employee count, from the company's filing | |
fin.annual | Revenue and net result by fiscal year | 5 fiscal years, FY2021 through FY2025: FY2021 revenue $12.64B, net result $991.59M; FY2022 revenue $13.40B, net result $675.61M; FY2023 revenue $14.28B, net result $717.80M; FY2024 revenue $15.83B, net result $1.14B; FY2025 revenue $17.36B, net result $1.49B | FMP | Financial Modeling Prep (FMP), from the company's 10-K income statements | |
fin.rev_mix | Reported revenue segments | Behavioral Health Services $7.43B · Acute Care Hospital Services $9.93B | FMP | Financial Modeling Prep (FMP) revenue segmentation, from the company's 10-K | |
fin.gross_margin | Gross margin (trailing twelve months) | 44.6% | FMP | Financial Modeling Prep (FMP) key-metrics-ttm + ratios-ttm — A ratio our provider could not compute is absent rather than shown as zero. | |
fin.q_table.depth.2026-06-30.revenue_k | Revenue — period end 2026-06-30 | $4.64B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-06-30.sga_k | SG&A — period end 2026-06-30 | $2.14B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-06-30.operating_result_k | FMP standardized operating result — period end 2026-06-30 | $516.67M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-03-31.revenue_k | Revenue — period end 2026-03-31 | $4.50B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-03-31.sga_k | SG&A — period end 2026-03-31 | $2.13B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-03-31.operating_result_k | FMP standardized operating result — period end 2026-03-31 | $502.86M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-12-31.revenue_k | Revenue — period end 2025-12-31 | $4.49B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-12-31.sga_k | SG&A — period end 2025-12-31 | $2.09B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-12-31.operating_result_k | FMP standardized operating result — period end 2025-12-31 | $517.23M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-09-30.revenue_k | Revenue — period end 2025-09-30 | $4.50B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-09-30.sga_k | SG&A — period end 2025-09-30 | $2.11B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-09-30.operating_result_k | FMP standardized operating result — period end 2025-09-30 | $521.69M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
earn.history.depth.2026-07-27.revenue_actual | Revenue · reported — report date 2026-07-27 | $4.64B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-07-27.revenue_estimated | Revenue · estimate — report date 2026-07-27 | $4.58B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-07-27.eps_actual | EPS · reported — report date 2026-07-27 | $5.9800 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-07-27.eps_estimated | EPS · estimate — report date 2026-07-27 | $5.9400 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-04-27.revenue_actual | Revenue · reported — report date 2026-04-27 | $4.50B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-04-27.revenue_estimated | Revenue · estimate — report date 2026-04-27 | $4.39B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-04-27.eps_actual | EPS · reported — report date 2026-04-27 | $5.6200 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-04-27.eps_estimated | EPS · estimate — report date 2026-04-27 | $5.4100 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-02-25.revenue_actual | Revenue · reported — report date 2026-02-25 | $4.49B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-02-25.revenue_estimated | Revenue · estimate — report date 2026-02-25 | $4.50B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-02-25.eps_actual | EPS · reported — report date 2026-02-25 | $5.8800 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-02-25.eps_estimated | EPS · estimate — report date 2026-02-25 | $5.9200 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-10-27.revenue_actual | Revenue · reported — report date 2025-10-27 | $4.50B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-10-27.revenue_estimated | Revenue · estimate — report date 2025-10-27 | $4.50B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-10-27.eps_actual | EPS · reported — report date 2025-10-27 | $5.6900 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-10-27.eps_estimated | EPS · estimate — report date 2025-10-27 | $4.6600 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
fin.q_table | Quarterly income statement | 4 quarters through Q2 FY2026 | FMP | Financial Modeling Prep (FMP) · income statement (quarterly), as filed | |
fin.cash_investments | Cash and short-term investments | $138.80M | FMP | Financial Modeling Prep (FMP), from the company's balance sheet — Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability. Long-term investments are excluded and remain unclassified. Restrictions on cash and short-term investments require separate review. | |
fin.opcf_latest | Latest-quarter operating cash flow | $443.30M | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Period end: 2026-06-30. Negative operating cash flow means cash used. This figure is not a cash-runway estimate. | |
fin.long_term_investments | Long-term investments (classification unverified) | $0.00 | FMP | Financial Modeling Prep (FMP), from the company's balance sheet — Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability. | |
fin.total_debt | Total debt | $5.26B | FMP | Financial Modeling Prep (FMP), from the company's balance sheet — Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability. | |
fin.price_to_book | Price to book value | 1.38× | FMP | Financial Modeling Prep (FMP) key-metrics-ttm + ratios-ttm — A ratio our provider could not compute is absent rather than shown as zero. | |
fin.opcf.depth.2026-06-30.operating_cash_flow_m | Operating cash flow — period end 2026-06-30 | $443.30M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2026-03-31.operating_cash_flow_m | Operating cash flow — period end 2026-03-31 | $401.63M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2026-06-30.capex_m | Capital expenditure (reported) — period end 2026-06-30 | −$227.63M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2026-03-31.capex_m | Capital expenditure (reported) — period end 2026-03-31 | −$217.16M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2025-12-31.operating_cash_flow_m | Operating cash flow — period end 2025-12-31 | $574.69M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2025-12-31.capex_m | Capital expenditure (reported) — period end 2025-12-31 | −$281.22M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2025-09-30.operating_cash_flow_m | Operating cash flow — period end 2025-09-30 | $380.68M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2025-09-30.capex_m | Capital expenditure (reported) — period end 2025-09-30 | −$247.57M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
earn.pt_range | Analyst price target, low to high | $166.00 – $290.00 | FMP | Financial Modeling Prep (FMP) · price-target consensus — Captured Oct 5, 2026 · Coverage not supplied | |
earn.pt_consensus | Consensus analyst price target | $193.00 | FMP | Financial Modeling Prep (FMP) · price-target consensus — Captured Oct 5, 2026 · Coverage not supplied | |
earn.pt_median | Median analyst price target | $189.00 | FMP | Financial Modeling Prep (FMP) · price-target consensus — Captured Oct 5, 2026 · Coverage not supplied | |
own.insiders | Insider transactions via FMP | 18 transactions · 0 purchases, 0 sales, 18 other transactions · 6 identified insiders · of the newest 100 records, those within the last 180 days, newest dated May 27, 2026 | FMP | Financial Modeling Prep (FMP), carrying Form 4 transaction records — Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent. | |
own.institutions.depth.ownership_pct | Institutional ownership | 86.5% | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Period end Jun 30, 2026 | |
own.institutions.depth.ownership_pct_previous_quarter | Previous quarter · ownership | 84.5% | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Prior to period end Jun 30, 2026 | |
own.institutions.depth.holders | Reporting holders | 615 | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Period end Jun 30, 2026 | |
own.institutions.depth.holders_previous_quarter | Previous quarter · holders | 664 | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Prior to period end Jun 30, 2026 | |
own.top_holders.depth.holder_0.shares | First Eagle Investment Management, LLC — shares in provider snapshot | 4,554,670 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_1.shares | Blackrock, INC. — shares in provider snapshot | 4,059,826 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_2.shares | Vanguard Capital Management LLC — shares in provider snapshot | 3,392,199 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_3.shares | Vanguard Portfolio Management LLC — shares in provider snapshot | 2,452,177 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_4.shares | Dimensional Fund Advisors LP — shares in provider snapshot | 2,210,595 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. |
UNRECORDED — 3 facts from stored observations whose source was not recorded
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
earn.history | Reported versus estimated, recent quarters | EPS beat 6 of 8 | UNRECORDED | Stored earnings-history observation — Captured 2026-10-04 | |
fin.scores | Distress and quality screens | Altman Z 3.11 · Piotroski F 8 | UNRECORDED | Stored financial-scores observation — Captured 2026-10-04 · Expired observation | |
px.range52 | 52-week range | $140.08 – $246.33 | UNRECORDED | Stored company-profile observation — Captured 2026-10-04 |
COMPUTED — 5 facts from our arithmetic, formula restated
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
fin.mcap_to_cash | Market value per dollar of cash and short-term investments | 77.09× | — | COMPUTED | Computed on this page from the figures above — The market capitalisation printed on this page divided by cash and short-term investments of $138.80M at Jun 30, 2026. Long-term investments are excluded and remain unclassified. Restrictions on cash and short-term investments require separate review. Market cap record date: 2026-10-05. Balance-sheet reference date: 2026-06-30. The inputs do not establish a single common source date for this ratio. |
div.ttm_per_share | Dividends per share, last 12 months (split-adjusted) | $0.80 | COMPUTED | Financial Modeling Prep (FMP) split-adjusted dividend history — Sum of 4 split-adjusted declared dividends with an ex-date in the 365 days to 2026-10-05, per current share. Ex-dates are not payment dates; special dividends are included. Not a declared annual rate. | |
div.ttm_yield | Dividend yield, last 12 months | 0.46% | COMPUTED | Financial Modeling Prep (FMP) split-adjusted dividend history and quote — Split-adjusted dividends with ex-dates in the trailing 365-day window divided by the packet price, on the same current-share basis. Price date follows the quote, latest price bar or packet-build day when unstamped. Not a forecast or declared annual rate. | |
earn.history.depth.2026-07-27.revenue_actual.comparison | Latest report · revenue vs estimate | Above estimate | Report date · | COMPUTED | Computed from Financial Modeling Prep (FMP) earnings — Earnings-history note — Method: compare reported revenue ($4.64B) with the recorded estimate ($4.58B) at displayed precision. Equal displayed values are in line. This compares reported results with recorded estimates, not investment returns. |
earn.history.depth.2026-07-27.eps_actual.comparison | Latest report · EPS vs estimate | Above estimate | Report date · | COMPUTED | Computed from Financial Modeling Prep (FMP) earnings — Earnings-history note — Method: compare reported EPS ($5.9800) with the recorded estimate ($5.9400) at displayed precision. Equal displayed values are in line. This compares reported results with recorded estimates, not investment returns. |
OURS — 2 facts from Stock Expert AI's own score and rank
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
ours.moonshot | MoonshotScore v2 | 94 of 100 · Exceptional · pillars 93 / 50 / 91 / 89 / 67 | OURS | Stock Expert AI MoonshotScore v2 engine | |
ours.moonshot_change | MoonshotScore movement | 94 (stored snapshot Oct 4, 2026) → 94 (current publication computed Oct 5, 2026) (0) | OURS | Stock Expert AI current score publication and immutable score snapshots |
Fact-family notes
- Quarterly statement note. Source series as of 2026-06-30. USD. The operating result is the FMP-standardized value supplied by FMP; it may differ from a filing’s GAAP loss from operations when the provider classifies separately presented items differently. It is not net income or cash flow. Applies to Fact IDs:
fin.q_table.depth.2026-06-30.revenue_k,fin.q_table.depth.2026-06-30.sga_k,fin.q_table.depth.2026-06-30.operating_result_k,fin.q_table.depth.2026-03-31.revenue_k,fin.q_table.depth.2026-03-31.sga_k,fin.q_table.depth.2026-03-31.operating_result_k,fin.q_table.depth.2025-12-31.revenue_k,fin.q_table.depth.2025-12-31.sga_k,fin.q_table.depth.2025-12-31.operating_result_k,fin.q_table.depth.2025-09-30.revenue_k,fin.q_table.depth.2025-09-30.sga_k,fin.q_table.depth.2025-09-30.operating_result_k. - Earnings-history note. Source series as of 2026-07-27. Dates are report dates, not fiscal period ends. Revenue is in USD; EPS is USD per share, rounded to four decimals. The earnings feed does not establish a basic, diluted or adjusted basis. Earnings-feed EPS may differ from statement EPS; the two series are not combined. Applies to Fact IDs:
earn.history.depth.2026-07-27.revenue_actual,earn.history.depth.2026-07-27.revenue_estimated,earn.history.depth.2026-07-27.revenue_actual.comparison,earn.history.depth.2026-07-27.eps_actual.comparison,earn.history.depth.2026-07-27.eps_actual,earn.history.depth.2026-07-27.eps_estimated,earn.history.depth.2026-04-27.revenue_actual,earn.history.depth.2026-04-27.revenue_estimated,earn.history.depth.2026-04-27.eps_actual,earn.history.depth.2026-04-27.eps_estimated,earn.history.depth.2026-02-25.revenue_actual,earn.history.depth.2026-02-25.revenue_estimated,earn.history.depth.2026-02-25.eps_actual,earn.history.depth.2026-02-25.eps_estimated,earn.history.depth.2025-10-27.revenue_actual,earn.history.depth.2025-10-27.revenue_estimated,earn.history.depth.2025-10-27.eps_actual,earn.history.depth.2025-10-27.eps_estimated. - Cash-flow note. Source series as of 2026-06-30. USD. Negative operating cash flow means cash used. Capital expenditure keeps the provider’s reported sign; it is not added here to estimate free cash flow or runway. Applies to Fact IDs:
fin.opcf.depth.2026-06-30.operating_cash_flow_m,fin.opcf.depth.2026-03-31.operating_cash_flow_m,fin.opcf.depth.2026-06-30.capex_m,fin.opcf.depth.2026-03-31.capex_m,fin.opcf.depth.2025-12-31.operating_cash_flow_m,fin.opcf.depth.2025-12-31.capex_m,fin.opcf.depth.2025-09-30.operating_cash_flow_m,fin.opcf.depth.2025-09-30.capex_m.
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com
Sources used for research written 2026-09-13
Historical evidence preserved with this analysis. Current figures are listed separately above.
| Evidence | Captured value | Source date | Source type | Source |
|---|---|---|---|---|
| Business description | Universal Health Services, Inc. (UHS), operating through its various divisions, is a healthcare entity that both owns and manages a network of acute care hospitals, along with outpatient and specialized behavioral health treatment centers. Its business operations are strategically bifurcated into two main segments: Acute Care Hospital Services and Behavioral Health Care Services. The hospitals under its management provide a comprehensive spectrum of medical provisions, encompassing general and specialty surgical interventions, internal medicine, obstetrics, urgent and emergency department services, diagnostic imaging (radiology), cancer therapy (oncology), advanced diagnostic procedures, cardiac care, pediatric medicine, pharmaceutical services, and mental health support. As of a reported date of February 24, 2022, the company's significant presence included the ownership or operation of 363 inpatient facilities, complemented by 40 outpatient and other specialized sites. These facilities are distributed across 39 U.S. states, the District of Columbia, the United Kingdom, and Puerto Rico. Beyond direct patient care, UHS also extends into commercial health insurance provision and offers a variety of crucial management support functions. These include centralized procurement, information technology infrastructure, financial oversight and control mechanisms, strategic facilities planning, physician talent acquisition, administrative staff management, marketing initiatives, and public relations efforts. Universal Health Services, Inc. was established in 1978 and maintains its principal executive offices in King of Prussia, Pennsylvania. | 2026-09-13 | FMP | Financial Modeling Prep (FMP) company profile |
| Revenue by segment | Behavioral Health Services: $7.43B; Acute Care Hospital Services: $9.93B | 2025-12-31 | FMP | Financial Modeling Prep (FMP) revenue segmentation, from the company's 10-K |
| Quarterly income statement (USD thousands) | Captured record · 8 entries
| 2026-06-30 | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements |
| Operating cash flow by quarter (USD millions) | Captured record · 8 entries
| 2026-06-30 | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements |
| Cash, investments and debt | Total debt: $5.26B; Liquidity basis: cash and short-term investments; Total liabilities: $8.28B; Cash and short-term investments: $138.80M; Cash and investments: $138.80M; Long-term investments: $0; Long-term investments classification: unclassified Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability. | 2026-06-30 | FMP | Financial Modeling Prep (FMP), from the company's balance sheet |
| Management outlook — dated call excerpts | Captured record · 4 entries
Selected verbatim statements from the latest available call, dated by the transcript provider. Management expectations, not completed milestones or guarantees. Relative dates retain the speaker's wording. | 2026-07-28 | OFFICIAL | Company earnings call, transcript via Financial Modeling Prep (FMP) |
| Employees | Count: 101,500 | 2025-12-31 | FMP | Financial Modeling Prep (FMP) employee count, from the company's filing |
| Annual revenue and net result (USD millions) | Captured record · 5 entries
| 2025-12-31 | FMP | Financial Modeling Prep (FMP), from the company's 10-K income statements |
| Reported versus estimated, last 8 quarters | Captured record · 8 entries
| 2026-07-27 | FMP | Financial Modeling Prep (FMP) earnings |
| Cash and investment components | Total basis: cash short and long-term investments; Total: $138.80M; Cash and short-term investments: $138.80M; Long-term investments: $0; Long-term investments classification: unclassified Sums the balance sheet's cash and short-term investments with its long-term investments.; The long-term investment field does not establish marketability; the sum is not a measure of available liquidity.; These provider fields do not establish investment access restrictions or explain differences from third-party cash figures. | 2026-06-30 | COMPUTED | Computed from the balance sheet |
| Cash and short-term investments over time (USD millions) | Captured record · 8 entries
| 2026-06-30 | FMP | Financial Modeling Prep (FMP), from the company's quarterly balance sheets |
| Cash against market value | As of: 2026-06-30; Cash basis: cash and short-term investments; Net cash: -$5.12B; Total debt: $5.26B; Cash and investments: $138.80M Price-based multiples captured at research time are not repeated here; the page shows each once, from current figures with their own dates. Cash is the latest reported cash and short-term investment balance; long-term investments are excluded. Market capitalization is the latest provider value.; The reported balance does not establish unrestricted availability or liquidation value.; The two are measured on different dates — the balance sheet is a quarter-end, the market cap is a recent close.; Debt is total debt as reported, including operating lease liabilities where the filer includes them. | 2026-06-30 | COMPUTED | Computed from the balance sheet and the latest market capitalization |
| Trailing twelve-month ratio set | Quick ratio: 1.04; Current ratio: 1.12; Debt to equity: 0.7; Net margin: 8.4%; Gross margin: 90.7%; Operating margin: 11.4%; Return on assets: 9.6%; Return on equity: 20.7% Price-based multiples captured at research time are not repeated here; the page shows each once, from current figures with their own dates. A ratio our provider could not compute is absent rather than shown as zero. | 2026-09-13 | FMP | Financial Modeling Prep (FMP) key-metrics-ttm + ratios-ttm |
| Distress and quality screens | Altman Z-score: 3.11; Piotroski F-score: 8 Altman Z below 1.8 is the conventional distress zone. The screen is built for manufacturers and industrials; for banks, insurers and property companies it is not a meaningful reading. | 2026-09-13 | FMP | Financial Modeling Prep (FMP) financial scores |
| Recent dividends paid | Captured record · 4 entries
Declared amounts per share on their ex-dates. A single payment does not establish an annual rate, and a special dividend is not separated here. | 2026-09-01 | FMP | Financial Modeling Prep (FMP) dividend history |
| Next earnings report | Date: 2026-10-26; EPS estimate: $5.23 per share; Revenue estimate: $4.72B The date is our provider's estimate until the company confirms it. | 2026-09-13 | FMP | Financial Modeling Prep (FMP) earnings calendar |
| Analyst revenue and earnings estimates (average) | Captured record · 4 entries
| 2026-09-13 | FMP | Financial Modeling Prep (FMP) analyst estimates |
| Recent SEC filings |
| 2026-08-21 | OFFICIAL | SEC EDGAR filer submissions |
| Most recent periodic reports | 2026-08-07 | OFFICIAL | SEC EDGAR filer submissions |
Data provided for informational purposes only.